Handelsbanken Fonder Ab Vanda Pharmaceuticals Inc. Transaction History

Handelsbanken Fonder Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$9.31 - $11.84 $172,235 - $219,040	-18,500 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$15.35 - $21.27 $87,495 - $121,239	5,700 Added 44.53%	18,500 $317,000
Q2 2021 Aug 03, 2021	BUY	$15.71 - $21.51 $3,142 - $4,302	200 Added 1.59%	12,800 $275,000
Q2 2020 Aug 13, 2020	BUY	$9.66 - $12.02 $121,716 - $151,452	12,600 New	12,600 $144,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $273M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.